目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Influenza Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising geriatric population
3.2.1.2. Increasing prevalence of diseases
3.2.1.3. Government initiatives to counter influenza
3.2.1.4. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. Product safety and high development cost
3.3. Influenza Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis

Chapter 4. Influenza Diagnostics Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Influenza Diagnostics Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. RIDT
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. RT-PCR
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Cell Culture
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Influenza Diagnostics Market: End-Use Estimates & Trend Analysis
5.1. End-Use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Influenza Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospitals
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. POCT
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Laboratories
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Influenza Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. 3M Company
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott Laboratories
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Becton, Dickinson and Company
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Meridian Bioscience, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Quidel Corporation.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. F. Hoffmann-La Roche Ltd.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. SA Scientific Ltd
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. SEKISUI Diagnostics
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Thermo Fisher Scientific, Inc.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Hologic, Inc.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America influenza diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 4 North America influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 6 U.S. influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 8 Canada influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe influenza diagnostics market, by region, 2018 - 2030 (USD Million)
Table 10 Europe influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 11 Europe influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12 Germany influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 13 Germany influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 14 UK influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 15 UK influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 France influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 17 France influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 19 Italy influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 21 Spain influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 Denmark influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 23 Denmark influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Sweden influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 25 Sweden influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 26 Norway influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 27 Norway influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific influenza diagnostics market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 30 Asia Pacific influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 31 China influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 32 China influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 Japan influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 34 Japan influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 35 India influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 36 India influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 South Korea influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 38 South Korea influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Australia influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 40 Australia influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 Thailand influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 42 Thailand influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America influenza diagnostics market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 45 Latin America influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 46 Brazil influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 47 Brazil influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 49 Mexico influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 51 Argentina influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 52 MEA influenza diagnostics market, by region, 2018 - 2030 (USD Million)
Table 53 MEA influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 54 MEA influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 55 South Africa influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 56 South Africa influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 60 UAE influenza diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 62 Kuwait influenza diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Influenza diagnostics market: market outlook
Fig. 14 Influenza diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Influenza diagnostics market driver impact
Fig. 20 Influenza diagnostics market restraint impact
Fig. 21 Influenza diagnostics market strategic initiatives analysis
Fig. 22 Influenza diagnostics market: Test Type movement analysis
Fig. 23 Influenza diagnostics market: Test Type outlook and key takeaways
Fig. 24 RIDT market estimates and forecast, 2018 - 2030
Fig. 25 RT-PCR estimates and forecast, 2018 - 2030
Fig. 26 Cell Culture market estimates and forecast, 2018 - 2030
Fig. 27 Others estimates and forecast, 2018 - 2030
Fig. 28 Influenza diagnostics Market: End Use movement Analysis
Fig. 29 Influenza diagnostics market: End use movement analysis
Fig. 30 Influenza diagnostics market: End use outlook and key takeaways
Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 32 POCT market estimates and forecasts,2018 - 2030
Fig. 33 Laboratories market estimates and forecasts,2018 - 2030
Fig. 34 Global influenza diagnostics market: Regional movement analysis
Fig. 35 Global influenza diagnostics market: Regional outlook and key takeaways
Fig. 36 Global influenza diagnostics market share and leading players
Fig. 37 North America market share and leading players
Fig. 38 Europe market share and leading players
Fig. 39 Asia Pacific market share and leading players
Fig. 40 Latin America market share and leading players
Fig. 41 Middle East & Africa market share and leading players
Fig. 42 North America, by country
Fig. 43 North America market estimates and forecasts, 2018 - 2030
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
Fig. 45 Canada market estimates and forecasts, 2018 - 2030
Fig. 46 Europe market estimates and forecasts, 2018 - 2030
Fig. 47 UK market estimates and forecasts, 2018 - 2030
Fig. 48 Germany market estimates and forecasts, 2018 - 2030
Fig. 49 France market estimates and forecasts, 2018 - 2030
Fig. 50 Italy market estimates and forecasts, 2018 - 2030
Fig. 51 Spain market estimates and forecasts, 2018 - 2030
Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
Fig. 54 Norway market estimates and forecasts, 2018 - 2030
Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 56 China market estimates and forecasts, 2018 - 2030
Fig. 57 Japan market estimates and forecasts, 2018 - 2030
Fig. 58 India market estimates and forecasts, 2018 - 2030
Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
Fig. 61 Australia market estimates and forecasts, 2018 - 2030
Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
Fig. 65 Argentina market estimates and forecasts, 2018 - 2030
Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 67 South Africa market estimates and forecasts, 2018 - 2030
Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 69 UAE market estimates and forecasts, 2018 - 2030
Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 71 Market share of key market players- influenza diagnostics market